Financial Metrics

BHC Bausch Health Companies Inc.

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	-1.08	—	USD/shares	10-Q	2017-05-09
Quarterly	2016-06-30	-0.88	+18.5%	USD/shares	10-Q	2017-08-08
Quarterly	2016-09-30	-3.49	-296.6%	USD/shares	10-Q	2017-11-07
Quarterly	2017-03-31	1.79	+151.3%	USD/shares	10-Q	2018-05-08
Quarterly	2017-06-30	-0.11	-106.1%	USD/shares	10-Q	2018-08-07
Quarterly	2017-09-30	3.69	+3454.5%	USD/shares	10-Q	2018-11-06
Quarterly	2018-03-31	-7.36	-299.5%	USD/shares	10-Q	2019-05-06
Quarterly	2018-06-30	-2.49	+66.2%	USD/shares	10-Q	2018-08-07
Quarterly	2018-09-30	-1.0	+59.8%	USD/shares	10-Q	2018-11-06
Quarterly	2019-03-31	-0.15	+85.0%	USD/shares	10-Q	2019-05-06
Quarterly	2019-09-30	-0.14	+6.7%	USD/shares	10-Q	2020-11-03
Quarterly	2020-03-31	-0.43	-207.1%	USD/shares	10-Q	2021-05-04
Quarterly	2020-06-30	-0.92	-114.0%	USD/shares	10-Q	2021-08-03
Quarterly	2020-09-30	0.2	+121.7%	USD/shares	10-Q	2021-11-02
Quarterly	2021-03-31	-1.71	-955.0%	USD/shares	10-Q	2022-05-10
Quarterly	2021-06-30	-1.66	+2.9%	USD/shares	10-Q	2022-08-09
Quarterly	2021-09-30	0.52	+131.3%	USD/shares	10-Q	2022-11-03
Quarterly	2022-03-31	-0.19	-136.5%	USD/shares	10-Q	2023-05-04
Quarterly	2022-06-30	-0.4	-110.5%	USD/shares	10-Q	2023-08-03
Quarterly	2022-09-30	1.1	+375.0%	USD/shares	10-Q	2023-11-02
Quarterly	2023-03-31	-0.55	-150.0%	USD/shares	10-Q	2024-05-02
Quarterly	2023-06-30	0.07	+112.7%	USD/shares	10-Q	2024-08-01
Quarterly	2023-09-30	-1.03	-1571.4%	USD/shares	10-Q	2024-10-31
Quarterly	2024-03-31	-0.17	+83.5%	USD/shares	10-Q	2025-05-01
Quarterly	2024-06-30	0.03	+117.6%	USD/shares	10-Q	2025-07-31
Quarterly	2024-09-30	-0.23	-866.7%	USD/shares	10-Q	2025-10-30
Quarterly	2025-03-31	-0.16	+30.4%	USD/shares	10-Q	2025-05-01
Quarterly	2025-06-30	0.4	+350.0%	USD/shares	10-Q	2025-07-31
Quarterly	2025-09-30	0.48	+20.0%	USD/shares	10-Q	2025-10-30
Annual	2016-12-31	-6.94	—	USD/shares	10-K	2019-02-20
Annual	2017-12-31	6.83	+198.4%	USD/shares	10-K	2020-02-19
Annual	2018-12-31	-11.81	-272.9%	USD/shares	10-K	2020-02-19
Annual	2019-12-31	-5.08	+57.0%	USD/shares	10-K	2022-02-23
Annual	2020-12-31	-1.58	+68.9%	USD/shares	10-K	2023-02-23
Annual	2021-12-31	-2.64	-67.1%	USD/shares	10-K	2024-02-22
Annual	2022-12-31	-0.62	+76.5%	USD/shares	10-K	2025-02-20
Annual	2023-12-31	-1.62	-161.3%	USD/shares	10-K	2026-02-19
Annual	2024-12-31	-0.13	+92.0%	USD/shares	10-K	2026-02-19
Annual	2025-12-31	0.42	+423.1%	USD/shares	10-K	2026-02-19

Balance Sheet

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	31978500000.0	—	USD	10-Q	2016-06-07
Quarterly	2016-06-30	31067300000.0	-2.8%	USD	10-Q	2016-08-09
Quarterly	2016-09-30	30445200000.0	-2.0%	USD	10-Q	2016-11-09
Quarterly	2016-12-31	29846000000.0	-2.0%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	28544000000.0	-4.4%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	28461000000.0	-0.3%	USD	10-Q	2017-08-08
Quarterly	2017-09-30	27141000000.0	-4.6%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	25444000000.0	-6.3%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	25268000000.0	-0.7%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	25088000000.0	-0.7%	USD	10-Q	2018-08-07
Quarterly	2018-09-30	24731000000.0	-1.4%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	24305000000.0	-1.7%	USD	10-Q	2019-11-04
Quarterly	2019-03-31	24181000000.0	-0.5%	USD	10-Q	2019-05-06
Quarterly	2019-06-30	24079000000.0	-0.4%	USD	10-Q	2019-08-06
Quarterly	2019-09-30	23566000000.0	-2.1%	USD	10-Q	2019-11-04
Quarterly	2019-12-31	25895000000.0	+9.9%	USD	10-Q	2020-11-03
Quarterly	2020-03-31	24428000000.0	-5.7%	USD	10-Q	2020-05-07
Quarterly	2020-06-30	24358000000.0	-0.3%	USD	10-Q	2020-08-06
Quarterly	2020-09-30	24343000000.0	-0.1%	USD	10-Q	2020-11-03
Quarterly	2020-12-31	23925000000.0	-1.7%	USD	10-Q	2021-11-02
Quarterly	2021-03-31	23738000000.0	-0.8%	USD	10-Q	2021-05-04
Quarterly	2021-06-30	23439000000.0	-1.3%	USD	10-Q	2021-08-03
Quarterly	2021-09-30	22358000000.0	-4.6%	USD	10-Q	2021-11-02
Quarterly	2021-12-31	22654000000.0	+1.3%	USD	10-Q	2022-11-03
Quarterly	2022-03-31	23168000000.0	+2.3%	USD	10-Q	2022-05-10
Quarterly	2022-06-30	21814000000.0	-5.8%	USD	10-Q	2022-08-09
Quarterly	2022-09-30	21215000000.0	-2.7%	USD	10-Q	2022-11-03
Quarterly	2022-12-31	20766000000.0	-2.1%	USD	10-Q	2023-11-02
Quarterly	2023-03-31	20653000000.0	-0.5%	USD	10-Q	2023-05-04
Quarterly	2023-06-30	20552000000.0	-0.5%	USD	10-Q	2023-08-03
Quarterly	2023-09-30	22430000000.0	+9.1%	USD	10-Q	2023-11-02
Quarterly	2023-12-31	22388000000.0	-0.2%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	22074000000.0	-1.4%	USD	10-Q	2024-05-02
Quarterly	2024-06-30	21660000000.0	-1.9%	USD	10-Q	2024-08-01
Quarterly	2024-09-30	21507000000.0	-0.7%	USD	10-Q	2024-10-31
Quarterly	2024-12-31	21616000000.0	+0.5%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	21510000000.0	-0.5%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	21738000000.0	+1.1%	USD	10-Q	2025-07-31
Quarterly	2025-09-30	21042000000.0	-3.2%	USD	10-Q	2025-10-30
Annual	2016-12-31	29846000000.0	—	USD	10-K	2018-02-28
Annual	2017-12-31	25444000000.0	-14.7%	USD	10-K	2019-02-20
Annual	2018-12-31	24305000000.0	-4.5%	USD	10-K	2020-02-19
Annual	2019-12-31	25895000000.0	+6.5%	USD	10-K	2021-02-24
Annual	2020-12-31	23925000000.0	-7.6%	USD	10-K	2022-02-23
Annual	2021-12-31	22654000000.0	-5.3%	USD	10-K	2023-02-23
Annual	2022-12-31	20766000000.0	-8.3%	USD	10-K	2024-02-22
Annual	2023-12-31	22388000000.0	+7.8%	USD	10-K	2025-02-20
Annual	2024-12-31	21616000000.0	-3.4%	USD	10-K	2026-02-19
Annual	2025-12-31	20817000000.0	-3.7%	USD	10-K	2026-02-19

Cash Flow

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	62000000.0	—	USD	10-Q	2017-05-09
Quarterly	2016-06-30	128000000.0	+106.5%	USD	10-Q	2017-08-08
Quarterly	2016-09-30	181000000.0	+41.4%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	38000000.0	-79.0%	USD	10-Q	2018-05-08
Quarterly	2017-06-30	75000000.0	+97.4%	USD	10-Q	2018-08-07
Quarterly	2017-09-30	118000000.0	+57.3%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	33000000.0	-72.0%	USD	10-Q	2019-05-06
Quarterly	2018-06-30	63000000.0	+90.9%	USD	10-Q	2019-08-06
Quarterly	2018-09-30	95000000.0	+50.8%	USD	10-Q	2019-11-04
Quarterly	2019-03-31	47000000.0	-50.5%	USD	10-Q	2020-05-07
Quarterly	2019-06-30	109000000.0	+131.9%	USD	10-Q	2020-08-06
Quarterly	2019-09-30	192000000.0	+76.1%	USD	10-Q	2020-11-03
Quarterly	2020-03-31	72000000.0	-62.5%	USD	10-Q	2021-05-04
Quarterly	2020-06-30	141000000.0	+95.8%	USD	10-Q	2021-08-03
Quarterly	2020-09-30	222000000.0	+57.4%	USD	10-Q	2021-11-02
Quarterly	2021-03-31	66000000.0	-70.3%	USD	10-Q	2022-05-10
Quarterly	2021-06-30	128000000.0	+93.9%	USD	10-Q	2022-08-09
Quarterly	2021-09-30	191000000.0	+49.2%	USD	10-Q	2022-11-03
Quarterly	2022-03-31	46000000.0	-75.9%	USD	10-Q	2023-05-04
Quarterly	2022-06-30	98000000.0	+113.0%	USD	10-Q	2023-08-03
Quarterly	2022-09-30	152000000.0	+55.1%	USD	10-Q	2023-11-02
Quarterly	2023-03-31	47000000.0	-69.1%	USD	10-Q	2024-05-02
Quarterly	2023-06-30	75000000.0	+59.6%	USD	10-Q	2024-08-01
Quarterly	2023-09-30	117000000.0	+56.0%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	82000000.0	-29.9%	USD	10-Q	2025-05-01
Quarterly	2024-06-30	160000000.0	+95.1%	USD	10-Q	2025-07-31
Quarterly	2024-09-30	231000000.0	+44.4%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	115000000.0	-50.2%	USD	10-Q	2025-05-01
Quarterly	2025-06-30	214000000.0	+86.1%	USD	10-Q	2025-07-31
Quarterly	2025-09-30	305000000.0	+42.5%	USD	10-Q	2025-10-30
Annual	2016-12-31	235000000.0	—	USD	10-K	2019-02-20
Annual	2017-12-31	171000000.0	-27.2%	USD	10-K	2020-02-19
Annual	2018-12-31	157000000.0	-8.2%	USD	10-K	2021-02-24
Annual	2019-12-31	270000000.0	+72.0%	USD	10-K	2022-02-23
Annual	2020-12-31	302000000.0	+11.9%	USD	10-K	2023-02-23
Annual	2021-12-31	269000000.0	-10.9%	USD	10-K	2024-02-22
Annual	2022-12-31	218000000.0	-19.0%	USD	10-K	2025-02-20
Annual	2023-12-31	215000000.0	-1.4%	USD	10-K	2026-02-19
Annual	2024-12-31	337000000.0	+56.7%	USD	10-K	2026-02-19
Annual	2025-12-31	397000000.0	+17.8%	USD	10-K	2026-02-19

Share Data

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	344900000.0	—	shares	10-Q	2017-05-09
Quarterly	2016-06-30	345000000.0	+0.0%	shares	10-Q	2017-08-08
Quarterly	2016-09-30	349500000.0	+1.3%	shares	10-Q	2017-11-07
Quarterly	2017-03-31	350500000.0	+0.3%	shares	10-Q	2018-05-08
Quarterly	2017-06-30	350100000.0	-0.1%	shares	10-Q	2018-08-07
Quarterly	2017-09-30	352300000.0	+0.6%	shares	10-Q	2018-11-06
Quarterly	2018-03-31	350700000.0	-0.5%	shares	10-Q	2019-05-06
Quarterly	2018-06-30	351300000.0	+0.2%	shares	10-Q	2019-08-06
Quarterly	2018-09-30	351500000.0	+0.1%	shares	10-Q	2019-11-04
Quarterly	2019-03-31	351300000.0	-0.1%	shares	10-Q	2020-05-07
Quarterly	2019-06-30	352100000.0	+0.2%	shares	10-Q	2020-08-06
Quarterly	2019-09-30	352400000.0	+0.1%	shares	10-Q	2020-11-03
Quarterly	2020-03-31	353400000.0	+0.3%	shares	10-Q	2021-05-04
Quarterly	2020-06-30	355300000.0	+0.5%	shares	10-Q	2021-08-03
Quarterly	2020-09-30	357800000.0	+0.7%	shares	10-Q	2021-11-02
Quarterly	2021-03-31	356800000.0	-0.3%	shares	10-Q	2022-05-10
Quarterly	2021-06-30	359100000.0	+0.6%	shares	10-Q	2022-08-09
Quarterly	2021-09-30	364000000.0	+1.4%	shares	10-Q	2022-11-03
Quarterly	2022-03-31	360800000.0	-0.9%	shares	10-Q	2023-05-04
Quarterly	2022-06-30	362200000.0	+0.4%	shares	10-Q	2023-08-03
Quarterly	2022-09-30	363400000.0	+0.3%	shares	10-Q	2023-11-02
Quarterly	2023-03-31	363300000.0	-0.0%	shares	10-Q	2024-05-02
Quarterly	2023-06-30	367100000.0	+1.0%	shares	10-Q	2024-08-01
Quarterly	2023-09-30	365400000.0	-0.5%	shares	10-Q	2024-10-31
Quarterly	2024-03-31	366800000.0	+0.4%	shares	10-Q	2025-05-01
Quarterly	2024-06-30	370200000.0	+0.9%	shares	10-Q	2025-07-31
Quarterly	2024-09-30	368400000.0	-0.5%	shares	10-Q	2025-10-30
Quarterly	2025-03-31	369600000.0	+0.3%	shares	10-Q	2025-05-01
Quarterly	2025-06-30	373100000.0	+0.9%	shares	10-Q	2025-07-31
Quarterly	2025-09-30	375500000.0	+0.6%	shares	10-Q	2025-10-30
Annual	2016-12-31	347300000.0	—	shares	10-K	2019-02-20
Annual	2017-12-31	351800000.0	+1.3%	shares	10-K	2020-02-19
Annual	2018-12-31	351300000.0	-0.1%	shares	10-K	2021-02-24
Annual	2019-12-31	352100000.0	+0.2%	shares	10-K	2022-02-23
Annual	2020-12-31	355000000.0	+0.8%	shares	10-K	2023-02-23
Annual	2021-12-31	358900000.0	+1.1%	shares	10-K	2024-02-22
Annual	2022-12-31	362000000.0	+0.9%	shares	10-K	2025-02-20
Annual	2023-12-31	364900000.0	+0.8%	shares	10-K	2026-02-19
Annual	2024-12-31	368000000.0	+0.8%	shares	10-K	2026-02-19
Annual	2025-12-31	375000000.0	+1.9%	shares	10-K	2026-02-19

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

20,817,000,000

Total Liabilities (latest annual)

25,989,000,000

Current Liabilities (latest annual)

4,180,000,000

Metrics

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	-0.0646	—	ratio	10-Q	2017-05-09
Quarterly	2016-06-30	-0.0563	+12.9%	ratio	10-Q	2017-08-08
Quarterly	2016-09-30	-0.2852	-407.0%	ratio	10-Q	2017-11-07
Quarterly	2017-03-31	0.1575	+155.2%	ratio	10-Q	2018-05-08
Quarterly	2017-06-30	-0.0092	-105.8%	ratio	10-Q	2018-08-07
Quarterly	2017-09-30	0.2398	+2710.8%	ratio	10-Q	2018-11-06
Quarterly	2018-03-31	-0.5564	-332.1%	ratio	10-Q	2019-05-06
Quarterly	2018-06-30	-0.2451	+56.0%	ratio	10-Q	2019-08-06
Quarterly	2018-09-30	-0.1084	+55.8%	ratio	10-Q	2019-11-04
Quarterly	2019-03-31	-0.0173	+84.1%	ratio	10-Q	2020-05-07
Quarterly	2019-06-30	-0.0632	-266.2%	ratio	10-Q	2020-08-06
Quarterly	2019-09-30	-0.0187	+70.4%	ratio	10-Q	2020-11-03
Quarterly	2020-03-31	-0.1924	-926.2%	ratio	10-Q	2021-05-04
Quarterly	2020-06-30	-0.5952	-209.4%	ratio	10-Q	2021-08-03
Quarterly	2020-09-30	0.1069	+118.0%	ratio	10-Q	2021-11-02
Quarterly	2021-03-31	4.8952	+4480.5%	ratio	10-Q	2022-05-10
Quarterly	2021-06-30	0.9705	-80.2%	ratio	10-Q	2022-08-09
Quarterly	2021-09-30	-1.4148	-245.8%	ratio	10-Q	2022-11-03
Quarterly	2022-03-31	0.4681	+133.1%	ratio	10-Q	2023-05-04
Quarterly	2022-06-30	-0.5494	-217.4%	ratio	10-Q	2023-08-03
Quarterly	2022-09-30	0.9307	+269.4%	ratio	10-Q	2023-11-02
Quarterly	2023-03-31	-1.4414	-254.9%	ratio	10-Q	2024-05-02
Quarterly	2023-06-30	0.0996	+106.9%	ratio	10-Q	2024-08-01
Quarterly	2023-09-30	1.6255	+1531.6%	ratio	10-Q	2024-10-31
Quarterly	2024-03-31	0.4425	-72.8%	ratio	10-Q	2025-05-01
Quarterly	2024-06-30	0.0044	-99.0%	ratio	10-Q	2025-07-31
Quarterly	2024-09-30	0.3802	+8529.8%	ratio	10-Q	2025-10-30
Quarterly	2025-03-31	0.3583	-5.7%	ratio	10-Q	2025-05-01
Quarterly	2025-06-30	0.8707	+143.0%	ratio	10-Q	2025-07-31
Quarterly	2025-09-30	0.5084	-41.6%	ratio	10-Q	2025-10-30
Annual	2016-12-31	-0.7391	—	ratio	10-K	2019-02-20
Annual	2017-12-31	0.4044	+154.7%	ratio	10-K	2020-02-19
Annual	2018-12-31	-1.4721	-464.0%	ratio	10-K	2021-02-24
Annual	2019-12-31	-1.5695	-6.6%	ratio	10-K	2022-02-23
Annual	2020-12-31	-0.9240	+41.1%	ratio	10-K	2023-02-23
Annual	2021-12-31	27.5588	+3082.7%	ratio	10-K	2024-02-22
Annual	2022-12-31	-0.8154	-103.0%	ratio	10-K	2025-02-20
Annual	2023-12-31	7.4512	+1013.8%	ratio	10-K	2026-02-19
Annual	2024-12-31	0.2236	-97.0%	ratio	10-K	2026-02-19
Annual	2025-12-31	0.3183	+42.4%	ratio	10-K	2026-02-19

8-K Material Event Details

95 filings · 204 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

321 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-03-31	LEUNG SANDRA	Dir	Equity grant / award A	Common Shares, No Par Value	5,946	$5.40	$32,108	44,354
2026-02-27	Charhon Jean-Jacques	EVP, CFO	Other disposed transaction F	Common Shares, No Par Value	49,060	$5.93	$290,926	706,478
2026-02-25	LEE STEVEN HYOSIG	SVP, Controller & CAO	Equity grant / award A	Common Shares, No Par Value	45,868	$0.00	$0	73,239
2026-02-09	APPIO THOMAS	Chief Executive Officer	Equity grant / award A	Common Shares, No Par Value	1,137,862	$0.00	$0	2,921,111
2025-12-31	Paulson John	Dir	Equity grant / award A	Common Shares, No Par Value	8,992	$0.00	$0	360,120
2025-11-25	PAULSON & CO. INC.	—	Open-market buy P	Common Stock, no par value	2,500,000	$6.25	$15,625,000	73,255,869
2025-09-30	Paulson John	Dir	Equity grant / award A	Common Shares, No Par Value	9,689	$0.00	$0	351,128
2025-09-08	Carson Seana	EVP, General Counsel	Open-market sell S	Common Shares, No Par Value	13,370	$7.31	$97,735	499,585
2025-09-05	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	51,337	$7.35	$377,327	512,955
2025-08-21	Lee Frank D.	Dir	Open-market sell S	Common Shares, No Par Value	15,912	$7.66	$121,886	73,795
2025-08-14	Paulson John	—	Open-market buy P	Common Stock, no par value	34,721,118	$9.00	$312,490,062	70,755,869
2025-08-13	Paulson John	—	Open-market buy P	Common Stock, no par value	86,409	$7.06	$610,048	36,034,751
2025-08-12	Paulson John	—	Open-market buy P	Common Stock, no par value	1,156,640	$6.88	$7,957,683	35,948,342
2025-08-11	Paulson John	—	Open-market buy P	Common Stock, no par value	2,000,000	$6.35	$12,700,000	34,791,702
2025-07-25	GOETTLER MICHAEL	Dir	Equity grant / award A	Common Shares, No Par Value	30,149	$0.00	$0	30,149
2025-07-17	Lenar Aimee J.	EVP, US Pharma	Equity grant / award A	Common Shares, No Par Value	30,847	$0.00	$0	260,774
2025-07-15	Lenar Aimee J.	EVP, US Pharma	Other disposed transaction F	Common Shares, No Par Value	22,736	$6.42	$145,965	229,927
2025-07-14	LEE STEVEN HYOSIG	SVP, Controller & CAO	Equity grant / award A	Common Shares, No Par Value	27,371	$0.00	$0	27,371
2025-06-30	Paulson John	Dir	Equity grant / award A	Common Shares, No Par Value	9,384	$0.00	$0	341,439
2025-06-13	Paulson John	—	Open-market buy P	Common Stock, no par value	3,564,059	$5.94	$21,170,510	32,791,702
2025-06-12	Paulson John	—	Open-market buy P	Common Stock, no par value	1,005,376	$5.47	$5,499,407	29,227,643
2025-06-11	Paulson John	—	Open-market buy P	Common Stock, no par value	1,029,098	$5.24	$5,392,474	28,222,267
2025-06-10	Paulson John	—	Open-market buy P	Common Stock, no par value	754,134	$5.05	$3,808,377	27,193,169
2025-05-16	Garcia Christian A	Dir	Equity grant / award A	Common Shares, No Par Value	54,347	$0.00	$0	89,707
2025-03-31	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	1,062	$6.47	$6,871	209,008
2025-02-28	Barresi John S	SVP, Controller & CAO	Other disposed transaction F	Common Shares, No Par Value	5,096	$7.44	$37,914	192,268
2025-02-28	Barresi John S	SVP, Controller & CAO	Other disposed transaction F	Common Shares, No Par Value	2,865	$7.44	$21,316	197,364
2025-02-26	Barresi John S	SVP, Controller & CAO	Equity grant / award A	Common Shares, No Par Value	49,823	$0.00	$0	200,229
2024-12-31	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	852	$8.06	$6,867	207,946
2024-12-02	Carson Seana	EVP, General Counsel	Open-market sell S	Common Shares, No Par Value	440	$8.35	$3,674	433,066
2024-11-29	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	1,692	$8.37	$14,162	433,506
2024-09-30	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	842	$8.16	$6,871	207,094
2024-09-06	Carson Seana	EVP, General Counsel	Open-market sell S	Common Shares, No Par Value	13,370	$6.21	$83,028	435,198
2024-09-05	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	51,337	$6.19	$317,776	448,568
2024-08-30	APPIO THOMAS	Chief Executive Officer	Other disposed transaction F	Common Shares, No Par Value	14,683	$5.93	$87,070	1,354,673
2024-08-19	Charhon Jean-Jacques	EVP, CFO	Equity grant / award A	Common Shares, No Par Value	298,838	$0.00	$0	298,838
2024-07-18	Barresi John S	SVP, Controller & CAO	Equity grant / award A	Common Shares, No Par Value	49,254	$0.00	$0	154,388
2024-07-15	Lenar Aimee J.	EVP, US Pharma	Equity grant / award A	Common Shares, No Par Value	144,352	$0.00	$0	144,352
2024-06-28	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	986	$6.97	$6,872	206,252
2024-06-20	Barresi John S	SVP, Controller & CAO	Other disposed transaction F	Common Shares, No Par Value	1,930	$6.73	$12,989	105,134
2024-05-17	Garcia Christian A	Dir	Equity grant / award A	Common Shares, No Par Value	35,360	$0.00	$0	35,360
2024-03-29	Paulson John	Dir	Equity grant / award A	Common Shares, No Par Value	5,890	$10.61	$62,493	208,309
2024-03-01	Barresi John S	SVP, Controller & CAO	Other disposed transaction F	Common Shares, No Par Value	3,188	$9.89	$31,529	107,064
2024-02-29	Barresi John S	SVP, Controller & CAO	Equity grant / award A	Common Shares, No Par Value	39,126	$0.00	$0	110,252
2024-02-29	Barresi John S	SVP, Controller & CAO	Equity grant / award A	Common Shares, No Par Value	39,126	$0.00	$0	110,252
2023-12-29	ROBERTSON RUSSEL C	Dir	Equity grant / award A	Common Shares, No Par Value	3,896	$8.02	$31,246	222,334
2023-12-05	Carson Seana	EVP, General Counsel	Open-market sell S	Common Shares, No Par Value	220	$7.38	$1,624	382,925
2023-12-01	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	1,691	$7.36	$12,446	383,145
2023-11-06	Carson Seana	EVP, General Counsel	Open-market sell S	Common Shares, No Par Value	43	$7.61	$327	384,836
2023-11-03	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	334	$7.57	$2,528	384,879
2023-09-29	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	836	$8.22	$6,872	168,402
2023-09-06	Carson Seana	EVP, General Counsel	Open-market sell S	Common Shares, No Par Value	6,685	$8.28	$55,352	385,213
2023-09-05	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	51,337	$8.35	$428,664	391,898
2023-09-01	APPIO THOMAS	Chief Executive Officer	Other disposed transaction F	Common Shares, No Par Value	14,111	$8.46	$119,379	967,010
2023-06-30	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	859	$8.00	$6,872	167,566
2023-06-20	Barresi John S	SVP, Controller & CAO	Other disposed transaction F	Common Shares, No Par Value	1,929	$7.40	$14,275	75,108
2023-05-19	Paulson John	Dir	Equity grant / award A	Common Shares, No Par Value	29,205	$0.00	$0	179,211
2023-03-31	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	848	$8.10	$6,869	137,502
2023-03-06	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	495	$9.17	$4,539	443,235
2023-03-06	Carson Seana	EVP, General Counsel	Open-market sell S	Common Shares, No Par Value	495	$9.17	$4,539	443,235
2023-03-03	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	780	$9.34	$7,285	443,730
2023-03-03	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	887	$9.16	$8,125	444,510
2023-03-03	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	1,637	$9.16	$14,995	445,397
2023-03-03	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	511	$9.16	$4,681	447,034
2023-03-03	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	765	$9.16	$7,007	447,545
2023-03-03	Carson Seana	EVP, General Counsel	Open-market sell S	Common Shares, No Par Value	780	$9.34	$7,285	443,730
2023-03-02	Carson Seana	EVP, General Counsel	Equity grant / award A · derivative	Non-Qualified Stock Options (right to purchase)	82,117	$0.00	$0	82,117
2023-03-02	Carson Seana	EVP, General Counsel	Equity grant / award A	Common Shares, No Par Value	95,119	$0.00	$0	448,310
2023-03-02	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	5,994	$9.25	$55,444	353,191
2023-02-28	Carson Seana	EVP, General Counsel	Open-market sell S	Common Shares, No Par Value	292	$9.32	$2,721	359,185
2023-02-27	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	768	$9.57	$7,350	359,477
2023-02-27	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	1,474	$9.57	$14,106	360,245
2023-01-03	Vadaketh Tom George	EVP, Chief Financial Officer	Other disposed transaction F	Common Shares, No Par Value	6,310	$6.28	$39,627	470,204
2022-12-30	DE SCHUTTER RICHARD U	Dir	Equity grant / award A	Common Shares, No Par Value	5,186	$6.28	$32,568	369,765
2022-12-01	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	1,691	$7.70	$13,021	361,719
2022-11-03	Carson Seana	EVP, General Counsel	Other disposed transaction F	Common Shares, No Par Value	334	$6.45	$2,154	363,410
2022-09-30	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	997	$6.89	$6,869	135,560
2022-09-30	ROBERTSON RUSSEL C	Dir	Equity grant / award A	Common Shares, No Par Value	4,989	$6.89	$34,374	171,943
2022-09-05	Vadaketh Tom George	EVP, Chief Financial Officer	Equity grant / award A	Common Shares, No Par Value	374,891	$0.00	$0	476,514
2022-09-01	APPIO THOMAS	Chief Executive Officer	Other disposed transaction D	Common Shares, No Par Value	15,389	$6.59	$101,414	491,900
2022-06-30	Paulson John	Dir	Equity grant / award A	Common Shares, No Par Value	2,251	$8.36	$18,818	123,267
2022-06-30	ROBERTSON RUSSEL C	Dir	Equity grant / award A	Common Shares, No Par Value	4,314	$8.36	$36,065	166,954
2022-06-24	KAVANAGH SARAH B	Dir	Equity grant / award A	Common Shares, No Par Value	34,387	$0.00	$0	117,447
2022-06-20	Barresi John S	SVP, Controller & CAO	Equity grant / award A	Common Shares, No Par Value	16,898	$0.00	$0	16,898
2022-05-13	Mulligan Richard	Dir	Equity grant / award A	Common Shares, No Par Value	2,317	$0.00	$0	2,317
2022-05-10	Carson Seana	EVP, General Counsel	Exercise / conversion M · derivative	Restricted Share Units	4,715	$9.40	$44,321	0
2022-05-10	Carson Seana	EVP, General Counsel	Equity grant / award A · derivative	Restricted Share Units	4,715	—	—	0
2022-05-10	Carson Seana	EVP, General Counsel	Exercise / conversion M · derivative	Restricted Share Units	2,752	$9.40	$25,869	0
2022-05-10	Carson Seana	EVP, General Counsel	Equity grant / award A · derivative	Restricted Share Units	2,752	—	—	0
2022-05-10	Carson Seana	EVP, General Counsel	Exercise / conversion M	Common Shares, No Par Value	4,715	—	—	76,037
2022-05-10	Carson Seana	EVP, General Counsel	Exercise / conversion M	Common Shares, No Par Value	2,752	—	—	71,322
2022-05-03	Munsch Frederick	SVP, Controller and CAO	Other disposed transaction F	Common Shares, No Par Value	747	$18.66	$13,939	22,435
2022-04-14	Spurr Robert	U.S. President-Pharma Business	Open-market sell S	Common Shares, No Par Value	1,595	$22.19	$35,393	90,506
2022-03-31	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	300	$22.85	$6,855	99,354
2022-03-15	Spurr Robert	U.S. President-Pharma Business	Open-market sell S	Common Shares, No Par Value	4,846	$22.20	$107,581	92,101
2022-03-10	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Other disposed transaction F	Common Shares, No Par Value	839	$22.56	$18,928	162,240
2022-03-08	Gordon Joseph F	Pres&Co-Head Bausch&Lomb/Int'l	Open-market sell S	Common Shares, No Par Value	3,889	$21.76	$84,625	93,139
2022-03-03	Spurr Robert	U.S. President-Pharma Business	Other disposed transaction F	Common Shares, No Par Value	4,074	$23.61	$96,187	96,947
2022-03-02	Gordon Joseph F	Pres&Co-Head Bausch&Lomb/Int'l	Open-market sell S	Common Shares, No Par Value	11,077	$23.37	$258,869	101,102
2022-02-28	PAPA JOSEPH C	Chairman & CEO	Other disposed transaction F	Common Shares, No Par Value	5,115	$24.06	$123,067	1,107,795
2022-02-27	PAPA JOSEPH C	Chairman & CEO	Exercise / conversion M · derivative	Restricted Share Units	208,231	$24.35	$5,070,425	0
2022-02-27	PAPA JOSEPH C	Chairman & CEO	Equity grant / award A · derivative	Restricted Share Units	208,231	—	—	0
2022-02-27	PAPA JOSEPH C	Chairman & CEO	Other disposed transaction F	Common Shares, No Par Value	13,206	$24.35	$321,566	1,112,910
2022-02-27	PAPA JOSEPH C	Chairman & CEO	Other disposed transaction F	Common Shares, No Par Value	100,351	$24.35	$2,443,547	1,139,299
2022-02-27	PAPA JOSEPH C	Chairman & CEO	Exercise / conversion M	Common Shares, No Par Value	208,231	—	—	1,239,650
2022-02-26	PAPA JOSEPH C	Chairman & CEO	Other disposed transaction F	Common Shares, No Par Value	13,183	$24.35	$321,006	1,126,116
2022-02-15	Spurr Robert	U.S. President-Pharma Business	Open-market sell S	Common Shares, No Par Value	3,251	$25.02	$81,340	60,299
2022-01-18	Spurr Robert	U.S. President-Pharma Business	Open-market sell S	Common Shares, No Par Value	3,251	$26.63	$86,574	63,550
2021-12-31	DE SCHUTTER RICHARD U	Dir	Equity grant / award A	Common Shares, No Par Value	1,245	$27.61	$34,374	319,588
2021-12-15	APPIO THOMAS	CEO, Pharma Business	Other disposed transaction F	Common Shares, No Par Value	3,461	$24.49	$84,760	317,225
2021-11-30	Miller Steven D	Dir	Open-market buy P	Common Shares, No Par Value	10,000	$24.17	$241,699	10,000
2021-11-30	Miller Steven D	Dir	Open-market buy P	Common Shares, No Par Value	50,000	$24.24	$1,211,825	60,780
2021-11-03	Munsch Frederick	SVP, Controller and CAO	Equity grant / award A	Common Shares, No Par Value	1,246	—	—	22,418
2021-10-01	Spurr Robert	U.S. President-Pharma Business	Other disposed transaction F	Common Shares, No Par Value	283	$28.60	$8,094	66,801
2021-09-30	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	246	$27.85	$6,851	98,805
2021-09-14	PAPA JOSEPH C	CHAIRMAN & CEO	Other disposed transaction F	Common Shares, No Par Value	5,010	$28.66	$143,587	1,031,419
2021-09-13	PAPA JOSEPH C	CHAIRMAN & CEO	Other disposed transaction F	Common Shares, No Par Value	3,549	$29.19	$103,595	1,036,429
2021-09-01	Spurr Robert	President, Salix	Equity grant / award A · derivative	Non-Qualified Stock Options (right to purchase)	31,400	$0.00	$0	31,400
2021-09-01	Spurr Robert	President, Salix	Equity grant / award A	Common Shares, No Par Value	9,026	$0.00	$0	67,084
2021-08-27	Spurr Robert	President, Salix	Other disposed transaction F	Common Shares, No Par Value	1,278	$28.95	$36,998	58,058
2021-08-05	VON ESCHENBACH ANDREW C.	Dir	Open-market buy P	Common Shares, No Par Value	1,400	$25.94	$36,316	38,647
2021-08-04	DE SCHUTTER RICHARD U	Dir	Open-market buy P	Common Shares, No Par Value	10,000	$25.01	$250,123	317,109
2021-06-30	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	234	$29.32	$6,861	98,559
2021-06-11	Eldessouky Sam	EVP & Chief Financial Officer	Open-market sell S	Common Shares, No Par Value	17,000	$31.68	$538,586	116,857
2021-06-02	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Exercise / conversion M · derivative	Non-Qualified Stock Options (right to purchase)	60,853	$0.00	$0	0
2021-06-02	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Exercise / conversion M · derivative	Non-Qualified Stock Options (right to purchase)	60,345	$0.00	$0	0
2021-06-02	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Open-market sell S	Common Shares, No Par Value	121,198	$31.83	$3,857,732	166,758
2021-06-02	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Exercise / conversion M	Common Shares, No Par Value	60,853	$15.32	$932,268	287,956
2021-06-02	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Exercise / conversion M	Common Shares, No Par Value	60,345	$14.38	$867,761	227,103
2021-06-01	Eldessouky Sam	EVP & Chief Financial Officer	Equity grant / award A · derivative	Non-Qualified Stock Options (right to purchase)	122,427	$32.03	$3,921,337	122,427
2021-06-01	Eldessouky Sam	EVP & Chief Financial Officer	Equity grant / award A	Common Shares, No Par Value	33,673	$0.00	$0	133,857
2021-05-26	WECHSLER AMY B	Dir	Open-market sell S	Common Shares, No Par Value	11,037	$31.79	$350,811	98,325
2021-04-30	Hale David Robert	Dir	Equity grant / award A	Common Shares, no par value	7,645	$0.00	$0	18,682
2021-03-31	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	216	$31.74	$6,856	101,717
2021-03-22	Miller Steven D	Dir	Equity grant / award A	Common Shares, No Par Value	744	$0.00	$0	844
2021-03-11	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Other disposed transaction F	Common Shares, No Par Value	796	$32.82	$26,125	166,758
2021-03-10	PAPA JOSEPH C	CHAIRMAN & CEO	Other disposed transaction F	Common Shares, No Par Value	231,188	$32.97	$7,622,268	1,039,978
2021-03-08	PAPA JOSEPH C	CHAIRMAN & CEO	Exercise / conversion M · derivative	Restricted Share Units	317,089	—	—	0
2021-03-08	PAPA JOSEPH C	CHAIRMAN & CEO	Equity grant / award A	Common Shares, No Par Value	108,254	$0.00	$0	1,271,166
2021-03-08	PAPA JOSEPH C	CHAIRMAN & CEO	Exercise / conversion M	Common Shares, No Par Value	317,089	—	—	1,162,912
2021-03-03	Spurr Robert	President, Salix	Equity grant / award A · derivative	Non-qualified Stock Options (right To Purchase)	32,749	$0.00	$0	32,749
2021-03-03	Spurr Robert	President, Salix	Equity grant / award A	Common Shares, No Par Value	23,892	$0.00	$0	59,336
2021-03-01	Spurr Robert	President, Salix	Other disposed transaction F	Common Shares, No Par Value	3,252	$31.42	$102,178	35,444
2020-12-31	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	330	$20.80	$6,864	101,501
2020-12-15	APPIO THOMAS	Pres&Co-Head Bausch&Lomb/Int'l	Other disposed transaction F	Common Shares, No Par Value	3,224	$20.61	$66,447	183,411
2020-12-04	Humphries William D.	President, Ortho-Dermatologics	Exercise / conversion M · derivative	Non-qualified Stock Options (right To Purchase)	114,055	$0.00	$0	0
2020-12-04	Humphries William D.	President, Ortho-Dermatologics	Open-market sell S	Common Shares, No Par Value	114,055	$19.87	$2,266,398	235,035
2020-12-04	Humphries William D.	President, Ortho-Dermatologics	Exercise / conversion M	Common Shares, No Par Value	114,055	$14.38	$1,640,111	349,090
2020-11-27	Humphries William D.	President, Ortho-Dermatologics	Exercise / conversion M · derivative	Non-qualified Stock Options (right To Purchase)	13,663	$0.00	$0	114,055
2020-11-27	Humphries William D.	President, Ortho-Dermatologics	Open-market sell S	Common Shares, No Par Value	13,663	$19.63	$268,207	235,035
2020-11-27	Humphries William D.	President, Ortho-Dermatologics	Exercise / conversion M	Common Shares, No Par Value	13,663	$14.38	$196,474	248,698
2020-11-24	Humphries William D.	President, Ortho-Dermatologics	Exercise / conversion M · derivative	Non-qualified Stock Options (right To Purchase)	21,658	$0.00	$0	127,718
2020-11-24	Humphries William D.	President, Ortho-Dermatologics	Open-market sell S	Common Shares, No Par Value	21,658	$19.63	$425,196	235,035
2020-11-24	Humphries William D.	President, Ortho-Dermatologics	Exercise / conversion M	Common Shares, No Par Value	21,658	$14.38	$311,442	258,176
2020-11-23	Humphries William D.	President, Ortho-Dermatologics	Exercise / conversion M · derivative	Non-qualified Stock Options (right To Purchase)	1,483	$0.00	$0	149,376
2020-11-23	Humphries William D.	President, Ortho-Dermatologics	Open-market sell S	Common Shares, No Par Value	1,483	$19.63	$29,115	235,035
2020-11-23	Humphries William D.	President, Ortho-Dermatologics	Exercise / conversion M	Common Shares, No Par Value	1,483	$14.38	$21,326	236,518
2020-10-02	Spurr Robert	President, Salix	Other disposed transaction F	Common Shares, No Par Value	276	$15.89	$4,386	38,696
2020-09-30	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	442	$15.54	$6,869	101,171
2020-09-15	Herendeen Paul	EVP and CFO	Other disposed transaction F	Common Shares, No Par Value	1,642	$15.91	$26,124	298,611
2020-09-15	PAPA JOSEPH C	CHAIRMAN & CEO	Other disposed transaction F	Common Shares, No Par Value	5,115	$15.91	$81,380	799,865
2020-09-14	PAPA JOSEPH C	CHAIRMAN & CEO	Other disposed transaction F	Common Shares, No Par Value	3,623	$15.40	$55,794	804,980
2020-09-08	Humphries William D.	President, Ortho-Dermatologics	Open-market sell S	Common Shares, No Par Value	5,667	$16.17	$91,635	235,035
2020-08-28	Spurr Robert	President, Salix	Other disposed transaction F	Common Shares, No Par Value	1,278	$17.00	$21,726	38,972
2020-08-17	Humphries William D.	President, Ortho-Dermatologics	Other disposed transaction F	Common Shares, No Par Value	4,567	$17.48	$79,831	240,702
2020-06-30	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	375	$18.29	$6,859	100,729
2020-06-05	ValueAct Holdings, L.P.	Dir	Open-market buy P	Common Shares, no par value	948,353	$19.24	$18,246,312	17,931,594
2020-06-05	ValueAct Holdings, L.P.	Dir	Open-market sell S	Common Shares, no par value	948,353	$19.24	$18,246,312	0
2020-05-14	Paulson John	—	Open-market buy P	Common Stock, no par value	585,100	$15.92	$9,314,792	25,839,035
2020-05-14	Paulson John	—	Open-market buy P	Common Stock, no par value	624,900	$15.87	$9,917,163	25,253,935
2020-05-14	Paulson John	—	Open-market buy P	Common Stock, no par value	70,000	$15.65	$1,095,500	24,629,035
2020-05-14	Paulson John	—	Open-market buy P	Common Stock, no par value	348,920	$15.85	$5,530,382	24,559,035
2020-05-13	Paulson John	—	Open-market buy P	Common Stock, no par value	645,844	$16.70	$10,785,595	24,210,115
2020-05-13	Paulson John	—	Open-market buy P	Common Stock, no par value	80,300	$16.58	$1,331,374	23,564,271
2020-05-13	Paulson John	—	Open-market buy P	Common Stock, no par value	603,900	$16.32	$9,855,648	23,483,971
2020-05-12	Paulson John	—	Open-market buy P	Common Stock, no par value	799,900	$17.24	$13,790,276	22,880,071
2020-05-12	Paulson John	—	Open-market buy P	Common Stock, no par value	678,400	$17.47	$11,851,648	22,080,171
2020-05-12	Paulson John	—	Open-market buy P	Common Stock, no par value	374,836	$17.33	$6,495,908	21,401,771
2020-05-12	Paulson John	—	Open-market buy P	Common Stock, no par value	162,900	$17.50	$2,850,750	21,026,935
2020-05-12	Paulson John	—	Open-market buy P	Common Stock, no par value	25,000	$17.30	$432,500	20,864,035
2020-05-04	PAPA JOSEPH C	CHAIRMAN & CEO	Other disposed transaction F	Common Shares, No Par Value	95,489	$17.16	$1,638,591	808,603
2020-05-01	WECHSLER AMY B	Dir	Equity grant / award A	Common Shares, No Par Value	11,037	$0.00	$0	100,354
2020-05-01	Hale David Robert	Dir	Equity grant / award A	Common Shares, no par value	11,037	$0.00	$0	21,046
2020-04-29	Hale David Robert	Dir	Other disposed transaction F	Common Shares, no par value	624	$18.11	$11,301	10,009
2020-03-31	WECHSLER AMY B	Dir	Equity grant / award A	Common Stock, No Par Value	443	$15.50	$6,866	89,317
2020-03-12	Ross Thomas W. Sr.	Dir	Open-market buy P	Common Stock, No Par Value	2,500	$15.54	$38,838	79,242
2020-03-10	DE SCHUTTER RICHARD U	Dir	Open-market buy P	Common Stock, No Par Value	3,800	$18.26	$69,377	13,800
2020-03-10	VON ESCHENBACH ANDREW C.	Dir	Open-market buy P	Common Shares, No Par Value	1,100	$18.18	$19,996	18,565
2020-03-09	PAPA JOSEPH C	CHAIRMAN & CEO	Other disposed transaction F	Common Shares, No Par Value	18,488	$20.96	$387,508	904,092
2020-03-03	DE SCHUTTER RICHARD U	Dir	Open-market buy P	Common Stock, No Par Value	5,000	$23.08	$115,415	279,250
2020-03-02	PAPA JOSEPH C	CHAIRMAN & CEO	Other disposed transaction F	Common Shares, No Par Value	4,925	$22.52	$110,911	922,580
2020-02-28	PAPA JOSEPH C	CHAIRMAN & CEO	Other disposed transaction F	Common Shares, No Par Value	9,269	$24.44	$226,534	927,505
2020-02-26	PAPA JOSEPH C	CHAIRMAN & CEO	Equity grant / award A · derivative	Non-qualified Stock Options (right To Purchase)	341,114	$0.00	$0	341,114
2020-02-26	PAPA JOSEPH C	CHAIRMAN & CEO	Equity grant / award A	Common Shares, No Par Value	81,040	$0.00	$0	936,774
2020-02-20	Humphries William D.	President, Ortho-Dermatologics	Other disposed transaction F	Common Stock, No Par Value	56,532	$26.46	$1,495,837	234,027
2020-02-19	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Exercise / conversion M · derivative	Restricted Share Units	7,864	—	—	0
2020-02-19	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Exercise / conversion M	Common Shares, No Par Value	7,864	—	—	55,029
2020-02-19	Humphries William D.	President, Ortho-Dermatologics	Exercise / conversion M · derivative	Restricted Share Units	20,911	—	—	0
2020-02-19	Humphries William D.	President, Ortho-Dermatologics	Equity grant / award A	Common Stock, No Par Value	105,783	$0.00	$0	290,559
2020-02-19	Humphries William D.	President, Ortho-Dermatologics	Exercise / conversion M	Common Stock, No Par Value	20,911	—	—	184,776
2020-01-07	Gordon Joseph F	Pres&Co-Head Bausch&Lomb/Int'l	Other disposed transaction F	Common Shares, No Par Value	2,118	$29.42	$62,312	49,078
2020-01-03	Humphries William D.	President, Ortho-Dermatologics	Other disposed transaction F	Common Stock, No Par Value	14,559	$29.92	$435,605	163,865
2019-12-31	WECHSLER AMY B	Dir	Equity grant / award A	Common Stock, No Par Value	1,065	$29.92	$31,865	88,874
2019-12-16	APPIO THOMAS	Pres&Co-Head Bausch&Lomb/Int'l	Other disposed transaction F	Common Stock, No Par Value	3,337	$31.00	$103,447	159,344
2019-09-30	WECHSLER AMY B	Dir	Equity grant / award A	Common Stock, No Par Value	1,458	$21.85	$31,857	87,809
2019-09-16	PAPA JOSEPH C	CHAIRMAN & CEO	Other disposed transaction F	Common Shares, No Par Value	5,115	$23.24	$118,873	855,734
2019-09-13	PAPA JOSEPH C	CHAIRMAN & CEO	Equity grant / award A	Common Shares, No Par Value	21,248	$0.00	$0	860,849
2019-09-13	PAPA JOSEPH C	CHAIRMAN & CEO	Open-market buy P	Common Shares, No Par Value	30,000	$23.31	$699,300	839,601
2019-08-23	Herendeen Paul	EVP and CFO	Other disposed transaction F	Common Stock, No Par Value	24,625	$22.40	$551,600	255,360
2019-08-19	APPIO THOMAS	Pres&Co-Head Bausch&Lomb/Int'l	Other disposed transaction F	Common Stock, No Par Value	8,362	$21.30	$178,111	162,681
2019-08-16	Humphries William D.	President, Ortho-Dermatologics	Equity grant / award A	Common Stock, No Par Value	30,703	$0.00	$0	178,424
2019-08-16	Humphries William D.	President, Ortho-Dermatologics	Open-market buy P	Common Stock, No Par Value	30,703	$21.18	$650,142	147,721
2019-08-12	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Open-market sell S	Common Stock, No Par Value	3,418	$22.45	$76,726	50,525
2019-08-09	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Other disposed transaction F	Common Stock, No Par Value	7,779	$22.39	$174,172	53,943
2019-07-11	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Open-market sell S	Common Stock, No Par Value	3,968	$24.81	$98,446	61,722
2019-06-28	WECHSLER AMY B	Dir	Equity grant / award A	Common Stock, No Par Value	1,263	$25.22	$31,853	86,351
2019-06-24	McKenna Mark C.	President, Salix	Other disposed transaction F	Common Shares, No Par Value	1,913	$23.82	$45,568	31,529
2019-06-13	ValueAct Holdings, L.P.	Dir	Other disposed transaction J	Common Shares, no par value	111,440	—	—	948,353
2019-06-04	Eldessouky Sam	SVP, CHIEF ACCOUNTING OFFICER	Other disposed transaction F	Common Stock, No Par Value	6,370	$20.73	$132,050	61,444
2019-05-06	Gordon Joseph F	Pres&Co-Head Bausch&Lomb/Int'l	Other disposed transaction F	Common Shares, No Par Value	693	$23.51	$16,292	51,196
2019-05-03	Hale David Robert	Dir	Equity grant / award A	Common Stock, no par value	10,633	$23.51	$249,982	20,518
2019-05-03	WECHSLER AMY B	Dir	Equity grant / award A	Common Stock, No Par Value	10,633	$23.51	$249,982	85,088
2019-05-01	Hale David Robert	Dir	Other disposed transaction F	Common Stock, no par value	3,996	$23.63	$94,425	9,885
2019-03-29	WECHSLER AMY B	Dir	Equity grant / award A	Common Stock, No Par Value	1,290	$24.70	$31,863	74,455
2019-03-08	PAPA JOSEPH C	CHAIRMAN & CEO	Other disposed transaction F	Common Shares, No Par Value	18,658	$23.56	$439,582	809,601
2019-02-28	PAPA JOSEPH C	CHAIRMAN & CEO	Equity grant / award A	Common Shares, No Par Value	30,000	$0.00	$0	747,077
2019-02-28	PAPA JOSEPH C	CHAIRMAN & CEO	Open-market buy P	Common Shares, No Par Value	30,000	$23.67	$710,100	717,077
2019-02-27	PAPA JOSEPH C	CHAIRMAN & CEO	Equity grant / award A · derivative	Non-qualified Stock Options (right To Purchase)	236,183	$0.00	$0	236,183
2019-02-27	PAPA JOSEPH C	CHAIRMAN & CEO	Equity grant / award A	Common Shares, No Par Value	81,182	$0.00	$0	768,259
2019-01-08	McKenna Mark C.	President, Salix	Other disposed transaction F	Common Shares, No Par Value	1,190	$21.25	$25,288	19,941
2019-01-03	Humphries William D.	President, Ortho-Dermatologics	Other disposed transaction F	Common Stock, No Par Value	13,311	$18.47	$245,854	101,797
2018-12-31	WECHSLER AMY B	Dir	Equity grant / award A	Common Stock, No Par Value	1,716	$18.47	$31,695	73,165
2018-12-14	APPIO THOMAS	Pres&Co-Head Bausch&Lomb/Int'l	Equity grant / award A	Common Stock, No Par Value	25,440	$0.00	$0	154,362
2018-12-14	APPIO THOMAS	Pres&Co-Head Bausch&Lomb/Int'l	Open-market buy P	Common Stock, No Par Value	25,440	$22.96	$584,018	128,922
2018-10-29	VON ESCHENBACH ANDREW C.	Dir	Equity grant / award A	Common Shares, No Par Value	5,832	$0.00	$0	6,832
2018-10-16	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Open-market sell S	Common Stock, No Par Value	4,542	$25.50	$115,821	51,456
2018-10-15	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Open-market sell S	Common Stock, No Par Value	15,404	$24.83	$382,481	55,998
2018-09-28	WECHSLER AMY B	Dir	Equity grant / award A	Common Stock, No Par Value	1,217	$25.67	$31,240	71,449
2018-09-14	Herendeen Paul	EVP and CFO	Equity grant / award A	Common Stock, No Par Value	10,000	$0.00	$0	226,866
2018-09-14	Herendeen Paul	EVP and CFO	Open-market buy P	Common Stock, No Par Value	10,000	$22.61	$226,100	216,866
2018-09-13	DE SCHUTTER RICHARD U	Dir	Open-market buy P	Common Stock, No Par Value	125,000	$23.96	$2,995,000	259,727
2018-08-23	Herendeen Paul	EVP and CFO	Other disposed transaction F	Common Stock, No Par Value	24,626	$22.37	$550,884	206,866
2018-08-20	APPIO THOMAS	Pres&Co-Head Bausch&Lomb/Int'l	Other disposed transaction F	Common Stock, No Par Value	5,501	$21.69	$119,317	104,585
2018-08-20	APPIO THOMAS	Pres&Co-Head Bausch&Lomb/Int'l	Other disposed transaction F	Common Stock, No Par Value	6,604	$21.69	$143,241	103,482
2018-08-09	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Other disposed transaction F	Common Stock, No Par Value	7,779	$23.52	$182,962	71,402
2018-06-29	DE SCHUTTER RICHARD U	Dir	Equity grant / award A	Common Stock, No Par Value	1,344	$23.24	$31,235	134,727
2018-06-29	Paulson John	Dir	Equity grant / award A	Common Stock, No Par Value	1,183	$23.24	$27,493	38,140
2018-06-04	Eldessouky Sam	SVP, CHIEF ACCOUNTING OFFICER	Other disposed transaction F	Common Stock, No Par Value	6,142	$22.08	$135,615	63,117
2018-05-15	DE SCHUTTER RICHARD U	Dir	Open-market buy P	Common Stock, No Par Value	10,000	$21.80	$218,000	10,000
2018-05-03	Hale David Robert	Dir	Equity grant / award A	Common Stock, no par value	14,285	$0.00	$0	35,897
2018-05-03	Hale David Robert	Dir	Equity grant / award A	Common Stock, no par value	13,881	$0.00	$0	35,493
2018-05-01	Hale David Robert	Dir	Other disposed transaction F	Common Stock, no par value	3,794	$18.07	$68,558	21,612
2018-03-30	WECHSLER AMY B	Dir	Equity grant / award A	Common Stock, No Par Value	1,962	$15.92	$31,235	55,007
2018-03-30	ROBERTSON RUSSEL C	Dir	Equity grant / award A	Common Stock, No Par Value	2,355	$15.92	$37,492	58,213
2018-03-13	Herendeen Paul	EVP and CFO	Open-market buy P	Common Stock, No Par Value	15,000	$16.10	$241,470	231,492
2018-03-08	DE SCHUTTER RICHARD U	Dir	Open-market buy P	Common Stock, No Par Value	10,000	$15.34	$153,400	106,062
2018-03-07	Eldessouky Sam	SVP, CHIEF ACCOUNTING OFFICER	Equity grant / award A · derivative	Restricted Share Units	7,104	$0.00	$0	7,104
2018-03-07	Eldessouky Sam	SVP, CHIEF ACCOUNTING OFFICER	Equity grant / award A · derivative	Non-qualified Stock Options (right To Purchase)	31,697	$0.00	$0	31,697
2018-03-07	Eldessouky Sam	SVP, CHIEF ACCOUNTING OFFICER	Equity grant / award A	Common Stock, No Par Value	10,654	$0.00	$0	69,259
2018-03-06	Paulson John	Dir	Open-market buy P	Common Stock, no par value	7,066,629	$15.40	$108,826,087	20,839,035
2018-03-06	Paulson John	Dir	Open-market sell S	Common Stock, no par value	7,066,629	$15.40	$108,826,087	13,772,406
2018-01-08	Eldessouky Sam	SVP, CHIEF ACCOUNTING OFFICER	Other disposed transaction F	Common Stock, No Par Value	1,826	$23.85	$43,550	58,605
2018-01-08	APPIO THOMAS	EVP, COMPANY GROUP CHAIRMAN	Other disposed transaction F	Common Stock, No Par Value	1,264	$23.85	$30,146	87,924
2018-01-03	Humphries William D.	EVP, COMPANY GROUP CHAIRMAN	Other disposed transaction F	Common Stock, No Par Value	14,730	$20.78	$306,089	115,108
2017-12-29	Paulson John	Dir	Equity grant / award A	Common Stock, no par value	1,323	$20.78	$27,492	21,349
2017-11-17	DE SCHUTTER RICHARD U	Dir	Open-market buy P	Common Stock, No Par Value	10,000	$14.33	$143,300	94,559
2017-11-16	Paulson John	Dir	Open-market sell S	Common Stock, no par value	344,216	$14.39	$4,952,821	20,839,035
2017-11-16	Paulson John	Dir	Open-market buy P	Common Stock, no par value	344,216	$14.40	$4,955,506	21,183,251
2017-09-29	Paulson John	Dir	Equity grant / award A	Common Stock, no par value	1,860	$14.33	$26,654	20,026
2017-08-23	Herendeen Paul	EVP and CFO	Other disposed transaction F	Common Stock, No Par Value	17,175	$14.14	$242,854	156,825
2017-08-21	DE SCHUTTER RICHARD U	Dir	Open-market buy P	Common Stock, No Par Value	4,900	$14.35	$70,315	82,379
2017-08-21	DE SCHUTTER RICHARD U	Dir	Open-market buy P	Common Stock, No Par Value	5,100	$14.31	$72,981	77,479
2017-08-18	APPIO THOMAS	EVP, COMPANY GROUP CHAIRMAN	Other disposed transaction F	Common Stock, No Par Value	5,687	$14.15	$80,471	89,188
2017-08-09	ACKERMANN CHRISTINA	EVP AND GENERAL COUNSEL	Other disposed transaction F	Common Stock, No Par Value	6,046	$15.37	$92,927	62,373
2017-06-30	Paulson John	Dir	Equity grant / award A	Common Stock, no par value	269	$0.00	$0	18,166
2017-06-07	Eldessouky Sam	SVP, CHIEF ACCOUNTING OFFICER	Other disposed transaction F	Common Stock, No Par Value	6,159	$12.51	$77,049	60,431
2017-05-11	DE SCHUTTER RICHARD U	Dir	Open-market buy P	Common Stock, No Par Value	20,000	$13.90	$278,000	70,572
2017-05-10	APPIO THOMAS	EVP, COMPANY GROUP CHAIRMAN	Other disposed transaction F	Common Stock, No Par Value	3,274	$9.71	$31,791	94,875
2017-05-08	DE SCHUTTER RICHARD U	Dir	Other disposed transaction F	Common Stock, no par value	2,148	$9.66	$20,750	50,572
2017-05-05	Hale David Robert	Dir	Equity grant / award A	Common Stock, No Par Value	25,406	$0.00	$0	38,209
2017-05-05	DE SCHUTTER RICHARD U	Dir	Equity grant / award A	Common Stock, no par value	25,406	$0.00	$0	52,720
2017-05-03	Hale David Robert	Dir	Other disposed transaction F	Common Stock, No Par Value	3,923	$9.66	$37,896	12,803
2017-03-31	WECHSLER AMY B	Dir	Equity grant / award A	Common Stock, no par value	2,460	$11.03	$27,134	22,150
2017-03-28	APPIO THOMAS	EVP, COMPANY GROUP CHAIRMAN	Equity grant / award A	Common Stock, no par value	63,742	$0.00	$0	98,149
2017-03-14	Pershing Square Capital Management, L.P.	Dir	Open-market sell S · derivative	Call Option (call equivalent position)	91,200	$0.30	$27,360	0
2017-03-14	Herendeen Paul	EVP and CFO	Open-market buy P	Common Stock, no par value	24,000	$10.72	$257,280	174,000
2017-03-13	Pershing Square Capital Management, L.P.	Dir	Open-market buy P · derivative	Put Option (call equivalent position)	9,120,000	$47.65	$434,568,000	0
2017-03-13	Pershing Square Capital Management, L.P.	Dir	Open-market sell S	Common Stock, no par value	18,114,432	$11.00	$199,258,752	0
2017-03-01	Eldessouky Sam	SVP, CHIEF ACCOUNTING OFFICER	Equity grant / award A · derivative	Non-Qualified Stock Options (right to purchase)	31,430	$0.00	$0	31,430
2017-03-01	Humphries William D.	EVP, COMPANY GROUP CHAIRMAN	Equity grant / award A · derivative	Non-Qualified Stock Options (right to purchase)	150,859	$0.00	$0	150,859
2017-01-06	Eldessouky Sam	SVP, CHIEF ACCOUNTING OFFICER	Equity grant / award A · derivative	Restricted Share Units	8,534	$0.00	$0	8,534
2017-01-06	Eldessouky Sam	SVP, CHIEF ACCOUNTING OFFICER	Equity grant / award A	Common Stock, no par value	12,799	$0.00	$0	66,590
2017-01-03	DE SCHUTTER RICHARD U	Dir	Equity grant / award A	Common Stock, no par value	11,190	$15.24	$170,536	15,190
2017-01-02	Humphries William D.	EVP, Company Group Chairman	Equity grant / award A · derivative	Restricted Share Units	41,002	$0.00	$0	41,002
2017-01-02	Humphries William D.	EVP, Company Group Chairman	Equity grant / award A	Common Stock, no par value	129,838	$0.00	$0	129,838
2016-12-30	WECHSLER AMY B	Dir	Equity grant / award A	Common Stock, no par value	1,721	$14.52	$24,989	19,690
2016-12-14	Ross Thomas W. Sr.	Dir	Open-market buy P	Common Stock, no par value	5,000	$14.73	$73,650	26,822
2016-12-12	Pershing Square Capital Management, L.P.	Dir	Open-market buy P · derivative	Call Option (put equivalent position)	9,120,000	$0.01	$91,200	0
2016-12-12	Pershing Square Capital Management, L.P.	Dir	Open-market sell S	Common Stock, no par value	3,476,690	$14.85	$51,628,846	18,114,432
2016-12-05	Whitaker Anne Clem	EVP, Company Group Chairman	Other disposed transaction F	Common Stock, no par value	6,012	$18.00	$108,216	158,544
2016-12-05	Whitaker Anne Clem	EVP, Company Group Chairman	Other disposed transaction F	Common Stock, no par value	6,505	$18.00	$117,090	158,885
2016-11-04	Rosiello Robert L.	EVP, Corp Dev & Strategy	Other disposed transaction F	Common Stock, no par value	817	$22.06	$18,023	532,370
2016-09-30	INGRAM ROBERT ALEXANDER	Dir	Equity grant / award A	Common Stock, no par value	865	$24.55	$21,236	88,463
2016-08-22	Herendeen Paul	EVP, Chief Financial Officer	Equity grant / award A · derivative	Non-Qualified Stock Options (right to purchase)	1,000,000	$0.00	$0	1,000,000
2016-08-22	Herendeen Paul	EVP, Chief Financial Officer	Equity grant / award A	Common Stock, no par value	150,000	$0.00	$0	150,000
2016-08-11	KARABELAS ARGERIS N	Dir	Open-market buy P	Common Stock, no par value	4,000	$24.65	$98,600	20,726
2016-08-10	ACKERMANN CHRISTINA	EVP and General Counsel	Equity grant / award A · derivative	Non-Qualified Stock Options (right to purchase)	39,469	$0.00	$0	39,469
2016-08-08	ACKERMANN CHRISTINA	EVP and General Counsel	Equity grant / award A	Common Stock, no par value	122,762	$0.00	$0	122,762
2016-08-03	Rosiello Robert L.	EVP, Chief Financial Officer	Other disposed transaction F	Common Stock, no par value	1,338	$23.54	$31,497	533,187
2016-08-02	Whitaker Anne Clem	EVP, Company Group Chairman	Other disposed transaction F	Common Stock, no par value	834	$23.54	$19,632	158,544
2016-07-27	KAVANAGH SARAH B	Dir	Equity grant / award A	Common Stock, no par value	14,458	$0.00	$0	14,458
2016-07-01	Hale David Robert	Dir	Other disposed transaction F	Common Stock, no par value	34	$23.78	$809	17,840
2016-06-30	INGRAM ROBERT ALEXANDER	Dir	Equity grant / award A	Common Stock, no par value	1,080	$20.14	$21,751	87,598
2016-06-17	Hale David Robert	Dir	Equity grant / award A	Common Stock, no par value	16,726	$0.00	$0	17,874
2016-06-13	Ross Thomas W. Sr.	Dir	Open-market buy P	Common Stock, no par value	4,000	$24.40	$97,600	21,882
2016-06-09	Pershing Square Capital Management, L.P.	Dir	Open-market sell S · derivative	Put Option (call equivalent position)	9,120,000	$37.09	$338,251,680	9,120,000
2016-06-09	Pershing Square Capital Management, L.P.	Dir	Open-market buy P · derivative	Call Option (call equivalent position)	91,200	$4.00	$364,800	91,200
2016-06-09	Pershing Square Capital Management, L.P.	Dir	Open-market sell S · derivative	Call Option (call equivalent position)	9,120,000	$0.03	$273,600	0
2016-06-09	Pershing Square Capital Management, L.P.	Dir	Open-market buy P · derivative	Put Option (call equivalent position)	9,120,000	$35.80	$326,496,000	0
2016-05-12	Whitaker Anne Clem	EVP, Company Group Chairman	Equity grant / award A	Common Stock, no par value	37,935	$0.00	$0	165,390
2016-05-02	Provencio Norma Ann	Dir	Equity grant / award A	Common Stock, no par value	1,188	$0.00	$0	144,899

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count